CD
Therapeutic Areas
KinCon biolabs Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Kinase Biosensor Platform | Kinase-driven diseases (e.g., cancer, inflammation) | Research/Discovery |
| Nuclear Receptor Platform | Metabolic, endocrine, oncological disorders | Research/Discovery |
| p53 Program | Cancer (p53 mutations) | Research/Discovery |
| E3 Ligase Program | Targeted Protein Degradation (various diseases) | Research/Discovery |